Salute e Benessere

Mindray Debuts Next-Generation BeneVision V Series Patient Monitoring System at…

The increasing utilisation of point-of-care ultrasound in the ICU has transformed patient assessment and management. The new BeneVision V Series connects with ultrasound systems, including the TE Air handheld ultrasound, to systemically integrate imaging data for more insightful decision-making support. This bedside innovation enables clinicians to get clearer ultrasound images on screen, so they can visualise, analyse and document ultrasound findings both in real-time and through historical…
PR Newswire
26/05/2025

Industry Forums at 137th Canton Fair Spotlight Emerging Trends and Global…

On April 23, another pivotal forum addressed brand globalization in the home and construction materials sector. Experts and company leaders shared approaches for strengthening reach in the international market. Professor Dai Yonghong of Shenzhen University emphasized the importance of combining AI with a deep understanding of Chinese market strengths to navigate global trade uncertainties. Shi Zhicheng from the China Quality Certification Center highlighted the need to embed carbon reduction…
PR Newswire
26/05/2025

ZLNA – Issuance of shares through set-off of option exercise fee

After the share capital increase related to the issuance of the new shares has been registered with the Norwegian Register of Business Enterprises, the Company will have a share capital of NOK 20,454,162, divided into 20,454,162 shares, each with a par value of NOK 1.For further information, please contact: Hans Vassgård Eid, CFO, Zelluna ASAEmail:hans.eid@zelluna.comPhone: +47 482 48632About Zelluna ASAZelluna's mission is to deliver transformative treatments with the...
Nasdaq GlobeNewswire
24/05/2025

Information on the total number of voting rights and shares

Information on the total number of voting rights and sharesMont-Saint-Guibert (Belgium), May 23, 2025, 10:30 pm CET / 4:30 pm ET –In accordance with article 15 of the Law of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels and Nasdaq: NYXH) publishes the below information following the issue of new shares. Share capital: EUR 6,430,026.16 Total number of securities carrying voting rights: 37,429,265 (all ordinary shares) Total number of voting...
Nasdaq GlobeNewswire
23/05/2025

Former British Prime Minister David Cameron, Medical Leaders and Researchers…

Symposium speakers included former UK Prime Minister, David Cameron, who chairs the Advisory Council for the Oxford-Harrington Rare Disease Centre — a unique transatlantic partnership between the University of Oxford, UK, and Harrington Discovery Institute at University Hospitals in Cleveland, aimed at driving breakthrough treatments for rare diseases. These diseases typically lack commercial incentive for private companies to develop therapies and treatments. Researchers often find their work…
PR Newswire
23/05/2025

Transactions of Managers and Closely Associated Persons

Attached is a copy of a filing with the Luxembourg Commission de Surveillance du Secteur Financier (CSSF) regarding transactions of managers and closely associated persons, announcing the acquisition of 95,000 shares in Alvotech at ISK 1,260 per share, by Alvogen Lux Holdings S.ár.l., the second largest shareholder in Alvotech. The date of the transaction is May 20, 2025. Alvogen Lux Holdings' largest shareholders are CVC (40%), Aztiq (30%) and Temasek (20%). Attachment Notification...
Nasdaq GlobeNewswire
23/05/2025

Acne Medicine Market to Reach USD 4.27 Billion by 2029 | Key Trends in OTC &…

Claim Your Free Report: https://reports.valuates.com/request/sample/QYRE-Auto-13R16186/Global_and_India_Acne_Medicine_Market Claim Your Free Report:https://reports.valuates.com/request/sample/QYRE-Auto-13R16186/Global_and_India_Acne_Medicine_Market Major Factors Driving the Growth of Acne Medicine Market: The acne medicine market is experiencing significant growth propelled by rising acne prevalence, evolving skincare routines, and the growing demand for effective, accessible...
PR Newswire
23/05/2025

Generic Pharmaceuticals Market Share worth $682.9 Billion, Globally, by 2030 -…

Market Overview and Growth Trajectory: Market Overview and Growth Trajectory: Generic Pharmaceuticals Market Size Growth: According to an exhaustive report by The Research Insights, the Generic Pharmaceuticals Market is experiencing significant growth. Multiple economic, regulatory and healthcare-related factors combine to stimulate strong growth in the generic pharmaceuticals market. The primary factor propelling this trend is the growing need for affordable healthcare options...
PR Newswire
23/05/2025

Breast Biopsy Devices Market worth US$3,261.7 million by 2030 with 6.5% CAGR |…

Outpatient procedures are becoming increasingly popular among patients, and various factors, including favorable reimbursement policies and a shift toward personalized treatment plans, are contributing to market growth. Together, these elements are driving the adoption and development of advanced breast biopsy technologies globally. Outpatient procedures are becoming increasingly popular among patients, and various factors, including favorable reimbursement policies and a shift toward...
PR Newswire
23/05/2025

LILYSILK Unveils Breathable, Stretchable, and Machine-Washable Silk Jersey…

LILYSILK's Silk Jersey is lighter than cotton and cooler than linen, making it a smart, stylish choice for those seeking comfort without compromising elegance. Crafted from 6A-grade mulberry silk, the brand has enhanced the material's durability with added stretch and machine-washable functionality — turning timeless silk into an easy-care staple. LILYSILK's Silk Jersey is lighter than cotton and cooler than linen, making it a smart, stylish choice for those seeking comfort without compromising…
PR Newswire
23/05/2025

AI Could Add $461 Billion to Global Healthcare--And These New Platforms Are…

VANCOUVER, BC, May 23, 2025 /PRNewswire/ -- Equity InsiderNews Commentary – A new report from Philips reveals a growing divide between doctors and patients when it comes to AI in healthcare. While 63% of surveyed healthcare professionals believe AI can help improve outcomes, only 48% of patients share that optimism. As researchers explore what's needed for successful AI adoption in healthcare, major players in tech and biotech are already moving ahead—recent updates have come from Avant…
PR Newswire
23/05/2025

SciBase publishes the Annual report for 2024

A printed version of the Annual report will only be distributed to shareholders who actively request a printed copy. A printed version of the Annual report will only be distributed to shareholders who actively request a printed copy. For more information, please contact: Michael Colérus, CFO Tel: +46 70 341 34 72 E-mail:michael.colerus@scibase.com Certified Advisor: Carnegie Investment Bank AB (publ) Phone: +46 (0)73 856 42 65 E-mail: certifiedadviser@carnegie.se The...
PR Newswire
23/05/2025

New Data and Deal Flow Signal a Turning Point for Precision-Driven Cancer…

VANCOUVER, BC, May 23, 2025 /PRNewswire/ -- Equity InsiderNews Commentary – With early onset cancer rates on the rise and funding being cut to NIH, the future for cancer patients is increasingly being shaped not by public institutions, but by the breakthroughs emerging from the private sector. For investors watching the next wave of oncology breakthroughs, companies like Oncolytics Biotech Inc. (NASDAQ: ONCY) (TSX: ONC), Akoya Biosciences, Inc. (NASDAQ: AKYA), Quanterix Corporation (NASDAQ…
PR Newswire
23/05/2025

CHMP recommends EU approval of Roche's Itovebi for PIK3CA-mutated, ER-positive…

Positive recommendation based on phase III INAVO120 data showing Itovebi TM(inavolisib) in combination with palbociclib and fulvestrant more than doubled progression-free survival in the first-line setting 1 The Itovebi-based regimen also demonstrated a statistically significant and clinically meaningful benefit in overall survival (OS) in the final OS analysisFinal OS data will be presented in an oral session at the 2025 American Society of Clinical Oncology Annual Meeting...
Nasdaq GlobeNewswire
23/05/2025

Evaxion to announce business update and first quarter 2025 financial results on…

COPENHAGEN, Denmark, May 23, 2025 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, will provide a business update and report its first quarter 2025 financial results on Tuesday, May 27, 2025, before opening of the Nasdaq CM.Evaxion's Executive Management will host a conference call and webcast the same day at 14:30 CET/08:30 EST, presenting the update and results as well as taking questions. This event is...
Nasdaq GlobeNewswire
23/05/2025

SpringWorks Therapeutics Receives Positive CHMP Opinion for Mirdametinib for the…

– If approved, mirdametinib is expected to be the first and only therapy in the European Union with marketing authorization for both adults and children with NF1-PN –– Decision from European Commission expected in the third quarter of 2025 – STAMFORD, Conn., May23, 2025(GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a commercial-stage biopharmaceutical company focused on severe rare diseases and cancer, announced today that the European Medicines Agency's (EMA)...
Nasdaq GlobeNewswire
23/05/2025

Major shareholder notification – BlackRock, Inc.

GN Store Nord A/S hereby announces that on May 22, 2025, pursuant to Section 38(1) and Section 39(1) of the Danish Capital Markets Act, it received a notification from BlackRock, Inc. stating that on May 21, 2025, BlackRock, Inc. increased its aggregate direct and indirect holding of shares and financial instruments, cf. Section 38 and Sections 39(2)(1) and (2) of the Danish Capital Markets Act, to above 5% of the share capital and voting rights in GN Store Nord A/S. For further information,...
Nasdaq GlobeNewswire
23/05/2025

Tiziana Life Sciences Announces Interview Highlighting Intranasal Foralumab for…

TLSA ) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal antibody, today announced advancements in moderate Alzheimer's disease treatment, showcased in a recent feature on a national public radio station across the United States. The advancement involves the use of Tiziana's novel nasal spray, foralumab, which is designed to combat brain...
Nasdaq GlobeNewswire
23/05/2025

Orion announces agreement with Shilpa Medicare for Recombinant Human Albumin for…

ORION CORPORATIONPRESS RELEASE23 MAY 2025 at 12.40 EEST Orion announces agreement with Shilpa Medicare for Recombinant Human Albumin for European market Orion Corporation and Shilpa Biocare Private Limited, a fully-owned subsidiary of Shilpa Medicare Limited (“Shilpa”), have entered into an agreement to commercialise Recombinant Human Albumin in Europe. Recombinant Human Albumin is a key plasma protein used in various therapeutic applications. Shilpa's Recombinant Human...
Nasdaq GlobeNewswire
23/05/2025

Menarini Group Presents Updated Data Underscoring the Combinability of…

"It is encouraging to see the positive preliminary efficacy and safety results when everolimus and ribocilib, respectively, are combined with elacestrant. These findings are consistent with the promising elacestrant plus abemaciclib cohort data from the same study that was presented last December, which also demonstrated favorable preliminary efficacy and safety in this setting," said Hope S. Rugo, MD, Director, Women's Cancers Program and Division Chief, Breast Medical Oncology, City…
PR Newswire
23/05/2025

New Visions for the Future: 4th China-CEEC Expo & International Consumer Goods…

The 80,000-square-meter exhibition space is divided into two main sections: the CEEC exhibition zone and the export consumer goods zone. Covering 20,000 square meters, the CEEC zone features over 400 exhibitors showcasing more than 8,000 unique products, including Czech beer, Slovenian honey, Hungarian down products, and Slovenian ski gear. Meanwhile, the export consumer goods zone features over 1,000 Chinese enterprises presenting high-quality offerings such as consumer goods and smart…
PR Newswire
23/05/2025

Sporting Goods Industry Unites: Urgent Action Needed to Tackle Physical…

The event welcomed WFSGI members adidas, Arena, ASICS, Decathlon, Nike, On, Puma, Speedo, Specialized and Shimano, alongside leaders from the World Health Organisation, the International Olympic Committee, Business at OECD (BIAC), the World Economic Forum, and global Ministers of Health. Introducing the report,WFSGI CEOEmma Zwiebler issued a call to action for increased cross-sector collaboration, explaining:"This is not just a health issue — it's an economic, social and...
PR Newswire
23/05/2025

England's NICE recommends FILSPARI® (sparsentan) as a treatment option for IgA…

ST. GALLEN, Switzerland, May 23, 2025 /PRNewswire/ -- CSL Vifor is pleased to announce that the National Institute for Health and Care Excellence (NICE) has published final draft guidance recommending that sparsentan can be used in the NHS in England as an option to treat primary IgA nephropathy in adults with a urine protein excretion of 1.0 g/day or more, or a urine protein-to-creatinine ratio of 0.75 g/g or more.3 NICE has provided guidance to ensure that only patients responding to treatment…
PR Newswire
23/05/2025

Inventiva reports 2025 First Quarter Financial Information¹

Cash and cash equivalents at €67.9 millionDaix (France), New York City (New York, United States), May 23, 2025– Inventiva (Euronext Paris and Nasdaq: IVA) (the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral therapies for the treatment of metabolic dysfunction-associated steatohepatitis (“MASH”), today reported financial information for the first quarter of 2025, including its cash, cash equivalents and revenues.Key Financial Results ...
Nasdaq GlobeNewswire
23/05/2025
Altri  Comunicati